Carrier to Present at Morgan Stanley’s 13th Annual Laguna Conference

Carrier Global Corporation (NYSE: CARR) Chairman & CEO David Gitlin and Senior Vice President & CFO Patrick Goris will speak at the 13th Annual Morgan Stanley Laguna Conference on Wednesday, September 10, 2025, at 10:45 a.m. PT (1:45 p.m. ET). https://mma.prnewswire.com/media/985365/Carrier_Logo.jpg The event will be broadcast live at ir.carrier.com. A webcast replay will be available […]

TXNM Energy Shareholders Overwhelmingly Approve Acquisition by Blackstone Infrastructure

TXNM Energy (NYSE: TXNM) shareholders voted overwhelmingly to approve the agreement under which Blackstone Infrastructure will acquire TXNM Energy at a special shareholders meeting held earlier today. Under the terms of the proposed agreement, TXNM Energy shareholders will receive $61.25 in cash for each share of TXNM Energy common stock held at closing. https://mma.prnewswire.com/media/2464779/TXNM_Energy_Logo.jpg Of

Gap Inc. Reports Second Quarter Fiscal 2025 Results

Net sales flat versus last year, with comparable sales positive for the 6th consecutive quarter Diluted earnings per share of $0.57 up 6% versus last year Cash, cash equivalents and short-term investments of $2.4 billion up 13% versus last year Reaffirms outlook for fiscal 2025 net sales growth Gap Inc. (NYSE: GAP), the largest specialty

Surrozen to Present at Upcoming Healthcare Investor Conference

Surrozen to Present at Upcoming Healthcare Investor Conference GlobeNewswire August 28, 2025 SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced that Company management will

ParaZero Announces First Half of 2025 Financial Results

ParaZero Announces First Half of 2025 Financial Results Sales increased by approximately 27% compared to the same period in 2024 GlobeNewswire August 28, 2025 KFAR SABA, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and

Crown Castle to Present at the Goldman Sachs 2025 Communacopia & Technology Conference

(NYSE:CCI), HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today that Sunit Patel, Crown Castle's Executive Vice President and Chief Financial Officer is scheduled to present on Thursday, September 11, 2025 at 12:30 p.m. Eastern Time at the Goldman Sachs 2025 Communacopia & Technology Conference. The presentation will

Vera Bradley, Inc. Announces Reporting Date for Second Quarter Fiscal Year 2026 Results

(NASDAQ:VRA), FORT WAYNE, Ind., Aug. 28, 2025 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced that it plans to report results for the second quarter ending August 2, 2025 of fiscal year 2026 (fiscal year ending January 31, 2026) at 8:00 a.m. Eastern Time on Thursday, September 11, 2025. The Company

CSLM Digital Asset Acquisition Corp III, Ltd Announces Closing of $230 Million Initial Public Offering

(NasdaqGM:KOYNU),(NasdaqGM:KOYN), FT. LAUDERDALE, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) — CSLM Digital Asset Acquisition Corp III, Ltd (the “Company”) (Nasdaq: KOYNU), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the

Genco Shipping & Trading Announces Appointment of John C. Wobensmith as Chairman and Kathleen C. Haines as Lead Independent Director

(NYSE:GNK), NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today announced that James G. Dolphin has retired from the Board. The decision is not the result of any disagreement on Genco's strategy,

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

(NasdaqGM:ZNTL), SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) — Zentalis(R) Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that members of the management team will participate in the following upcoming investor conferences: 2025 Wells Fargo Healthcare

Scroll to Top